Anemia drugs for cancer patients limited in CMS plan


    loading  Checking for direct PDF access through Ovid

Abstract

The move comes amid Food and Drug Administration warnings about the medications, and criticisms that manufacturer rebates encourage doctors to prescribe them.

    loading  Loading Related Articles